After the rejection of Lykos Therapeutics’ MDMA-based PTSD treatment tempered excitement for psychedelic therapeutics, a ...

Months after Massachusetts voters rejected a ballot question that would permit adults to use and grow certain psychedelic drugs, some state lawmakers have begun proposing bills to legalize psilocybin.

The largest life sciences association in the state recognized those driving discovery during its 32nd annual dinner meeting ...

The Food and Drug Administration (FDA) has not approved ketamine as a treatment for any psychiatric disorder. The only FDA-approved option is Spravato, a nasal spray made from a derivative of ketamine ...

"This provides further evidence for the use of esketamine nasal spray in this difficult-to-treat ... an intranasal formulation of racemic ketamine.

Compared with placebo, zavegepant nasal spray yielded sustained relief of acute pain and function in migraine.

The neffyinSchools program from ARS Pharma will provide eligible public and private K-12 schools in the United States with ...

Major depressive disorder (MDD) is a leading cause of disability worldwide, with a significant proportion of patients (10-20%) progressing to treatment-resistant depression (TRD).

Ketamine, a non-competitive N-methyl-D-aspartate receptor antagonist, has emerged as an effective therapeutic agent for the management of treatment-resistant depression. Repeated treatments with ...

Just a few puffs into each nostril, and you're protected against infection from nasty cold viruses - that is, according to claims made for many nasal sprays. Can they really do this?Well, not directly ...